Nectar LifesciencesNECLIFE 
$0.62-2.78%24h
-2.78%24h
Global rank19411
Market cap$140.14M
Change 7d0.92%
YTD Performance62.54%
SP500 benchmarkOutperform
P/E-0.58
P/S0.77
Revenue$181.64M
Earnings-$2.88M
Dividend yield-
Main Sector
Healthcare
Nectar Lifesciences (NECLIFE) Cash on Hand
NECLIFE Cash on Hand in 2022: $2.13M
According to Nectar Lifesciences latest financial reports the cash on hand of NECLIFE is $2.13M, an decrease of -2.02% to 2022. At the end of 2022 company had $2.17M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
NECLIFE Cash on Hand History from 2019 to 2023
-
Value:-
NECLIFE Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $2.13M | -2.02% |
| 2022 | $2.17M | -29.75% |
| 2021 | $3.09M | 21.17% |
| 2020 | $2.55M | -1.71% |
| 2019 | $2.60M | - |
View the Top Cash on Hand Companies 
